Cargando…
Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy
Cardiac hypertrophy without appropriate treatment eventually progresses to heart failure. Our recent data demonstrated that the immunoproteasome subunit β5i promotes cardiac hypertrophy. However, whether β5i is a promising therapeutic target for treating hypertrophic remodeling remains unknown. Here...
Autores principales: | Xie, Xin, Wang, Hong-Xia, Li, Nan, Deng, Ya-Wen, Bi, Hai-Lian, Zhang, Yun-Long, Xia, Yun-Long, Li, Hui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303343/ https://www.ncbi.nlm.nih.gov/pubmed/32595507 http://dx.doi.org/10.3389/fphar.2020.00885 |
Ejemplares similares
-
Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
por: Chen, Chen, et al.
Publicado: (2018) -
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation
por: Xie, Xin, et al.
Publicado: (2019) -
Gallic Acid Ameliorates Angiotensin II-Induced Atrial Fibrillation by Inhibiting Immunoproteasome- Mediated PTEN Degradation in Mice
por: Han, Dan, et al.
Publicado: (2020) -
Deficiency of the Immunoproteasome LMP10 Subunit Attenuates Angiotensin II-Induced Cardiac Hypertrophic Remodeling via Autophagic Degradation of gp130 and IGF1R
por: Yan, Wen, et al.
Publicado: (2020) -
The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor
por: Bi, Hai-Lian, et al.
Publicado: (2020)